The Lancet Global Health in conversation with

Meredith Hawkins and Nihal Thomas on type 5 diabetes


Listen Later

70 years ago this year, a researcher at University College of the West Indies in Jamaica published a paper in The Lancet describing a case series of patients with diabetes who did not have the typical hallmarks of type 1 or type 2 disease. They were young, underweight, resistant to insulin, and did not tend to have ketoacidosis. 

The condition was coined J-type diabetes, after Jamaica, and it was briefly recognised by WHO as malnutrition-related diabetes. However, WHO removed it from its official classification in 1999, because of insufficient evidence of its association with malnutrition. 

In this episode of In Conversation With, Professor Meredith Hawkins and Professor Nihal Thomas explain how this “lost” condition, which they estimate affects 25 million people worldwide, particularly in low- and middle-income countries, is now becoming more widely recognised and better understood, albeit with a long way to go in terms of additional research. They also propose a new name: type 5 diabetes. Listen now to explore the fascinating history of the disorder and the urgent need for effective treatments.

Read the full Viewpoint:

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00263-3/fulltext?dgcid=buzzsprout_icw_podcast_September_25_langlo

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Global Health in conversation withBy The Lancet Group

  • 5
  • 5
  • 5
  • 5
  • 5

5

2 ratings


More shows like The Lancet Global Health in conversation with

View all
Economist Podcasts by The Economist

Economist Podcasts

4,201 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

22 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

2 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Healthy Longevity in conversation with by The Lancet Group

The Lancet Healthy Longevity in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

eClinicalMedicine in conversation with by The Lancet Group

eClinicalMedicine in conversation with

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners